Sartorius Stedim Biotech S.A.
SRTOY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,780,000 | $2,775,500 | $3,492,700 | $2,886,977 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Cost of Goods Sold | $1,573,300 | $1,542,000 | $1,658,200 | $1,333,974 |
| Gross Profit | $1,206,700 | $1,233,500 | $1,834,500 | $1,553,003 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| R&D Expenses | $144,100 | $129,500 | $132,400 | $110,491 |
| G&A Expenses | $168,700 | $167,100 | $154,700 | $126,117 |
| SG&A Expenses | $648,500 | $616,200 | $601,200 | $531,764 |
| Sales & Mktg Exp. | $479,800 | $449,100 | $446,500 | $405,647 |
| Other Operating Expenses | $43,500 | $0 | $18,100 | $27,767 |
| Operating Expenses | $836,100 | $749,000 | $751,700 | $670,022 |
| Operating Income | $370,600 | $484,500 | $995,200 | $683,301 |
| % Margin | 13.3% | 17.5% | 28.5% | 23.7% |
| Other Income/Exp. Net | -$151,400 | -$83,400 | $135,200 | -$36,601 |
| Pre-Tax Income | $219,200 | $401,100 | $1,130,400 | $646,720 |
| Tax Expense | $40,700 | $89,000 | $250,500 | $232,411 |
| Net Income | $175,100 | $309,700 | $876,100 | $414,400 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS | 0.18 | 0.34 | 0.95 | 0.45 |
| % Growth | -47.1% | -64.2% | 111.1% | – |
| EPS Diluted | 0.18 | 0.34 | 0.95 | 0.45 |
| Weighted Avg Shares Out | 967,773 | 921,606 | 921,631 | 921,768 |
| Weighted Avg Shares Out Dil | 967,773 | 921,606 | 921,631 | 921,768 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18,900 | $6,200 | $500 | $276 |
| Interest Expense | $158,900 | $121,100 | $41,000 | $10,398 |
| Depreciation & Amortization | $301,700 | $237,600 | $181,700 | $141,556 |
| EBITDA | $670,500 | $755,700 | $1,330,700 | $811,959 |
| % Margin | 24.1% | 27.2% | 38.1% | 28.1% |